HomeCompareIFUS vs CL

IFUS vs CL: Dividend Comparison 2026

IFUS yields 8492.57% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IFUS wins by $11041986035131172.00M in total portfolio value
10 years
IFUS
IFUS
● Live price
8492.57%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11041986035131172.00M
Annual income
$10,792,008,505,664,056,000,000.00
Full IFUS calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — IFUS vs CL

📍 IFUS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIFUSCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IFUS + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IFUS pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IFUS
Annual income on $10K today (after 15% tax)
$721,868.37/yr
After 10yr DRIP, annual income (after tax)
$9,173,207,229,814,447,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, IFUS beats the other by $9,173,207,229,814,447,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IFUS + CL for your $10,000?

IFUS: 50%CL: 50%
100% CL50/50100% IFUS
Portfolio after 10yr
$5520993017565586.00M
Annual income
$5,396,004,252,832,028,000,000.00/yr
Blended yield
97.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

IFUS
No analyst data
Altman Z
7.4
Piotroski
5/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IFUS buys
0
CL buys
0
No recent congressional trades found for IFUS or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIFUSCL
Forward yield8492.57%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$11041986035131172.00M$40.8K
Annual income after 10y$10,792,008,505,664,056,000,000.00$5,401.96
Total dividends collected$11025302406276466.00M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IFUS vs CL ($10,000, DRIP)

YearIFUS PortfolioIFUS Income/yrCL PortfolioCL Income/yrGap
1← crossover$859,957$849,256.90$11,012$312.01+$848.9KIFUS
2$69,174,764$68,254,610.41$12,196$412.95+$69.16MIFUS
3$5,205,220,238$5,131,203,240.18$13,599$549.66+$5205.21MIFUS
4$366,419,711,261$360,850,125,605.98$15,288$736.64+$366419.70MIFUS
5$24,132,183,173,475$23,740,114,082,425.72$17,353$995.28+$24132183.16MIFUS
6$1,487,045,477,053,427$1,461,224,041,057,809.20$19,926$1,357.80+$1487045477.03MIFUS
7$85,742,407,458,414,640$84,151,268,797,967,470.00$23,194$1,873.82+$85742407458.39MIFUS
8$4,626,441,795,368,287,000$4,534,697,419,387,782,700.00$27,439$2,621.52+$4626441795368.26MIFUS
9$233,623,859,315,062,280,000$228,673,566,594,018,200,000.00$33,088$3,727.38+$233623859315062.25MIFUS
10$11,041,986,035,131,173,000,000$10,792,008,505,664,056,000,000.00$40,806$5,401.96+$11041986035131172.00MIFUS

IFUS vs CL: Complete Analysis 2026

IFUSStock

Impact Fusion International, Inc. engages in the business of marketing products in the health and wellness sector. The company focuses on the invention, development, and marketing of its proprietary products worldwide for the health of humans and animals. The company's products include Nutri-Mastic that supports digestive function, the immune system, vital organ health, healthy blood cells, and cardiac muscle and heart function; Intact Nutrition herbal health support products; Intact Endurance, which offers nutrients to increase body's optimal energy levels; Pet Intact nutritional supplements; and Equine Intact products. It also sells herbal health support beverages under the Mastic Blast Beverage brand; and alternative proprietary formulation for beef and dairy cattle under the Supreme Gold Plus brand. The company was formerly known as Red Reef Laboratories International, Inc. and changed its name to Impact Fusion International Inc. in April 2009. Impact Fusion International, Inc. was founded in 2002 and is based in Margate, Florida.

Full IFUS Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this IFUS vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IFUS vs SCHDIFUS vs JEPIIFUS vs OIFUS vs KOIFUS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.